OAB-055: Updated results of a phase 1, first-in-human study of ABBV-383, a BCMA × CD3 bispecific T-cell redirecting antibody, in patients with relapsed/refractory multiple myeloma
Titel:
OAB-055: Updated results of a phase 1, first-in-human study of ABBV-383, a BCMA × CD3 bispecific T-cell redirecting antibody, in patients with relapsed/refractory multiple myeloma
Auteur:
Voorhees, Peter Shah, Nina D’Souza, Anita Rodriguez, Cesar Weisel, Katja Teipel, Raphael Hurd, David Bueno, Orlando Pumford, Neil Rosenberg, Tanya Pothacamury, Rajvineeth Kumar Ross, Jeremy Polepally, Akshanth Lee, Shane Jin, Ziyi Talati, Chetasi Kumar, Shaji Vij, Ravi